BIOMAT Database Logo BIOMAT Database Logo

Synthesis and antiviral activities of enantiomeric 1-[2-(hydroxymethyl) cyclopropyl] methyl nucleosides. 2000

C Pierra, and S Olgen, and S C Cavalcanti, and Y C Cheng, and R F Schinazi, and C K Chu
Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens 30602, USA.

Cyclopropyl carbocyclic nucleosides have been synthesized from the key intermediate 2 which was converted to the mesylated cyclopropyl methyl alcohol 3. Condensation of compound 3 with various purine and pyrimidine bases gave the desired nucleosides. All synthesized nucleosides were evaluated for antiviral activity and cellular toxicity. Among them adenine 22 and guanine 23 derivatives showed moderate antiviral activity against HIV-1 and HBV. None of the other compounds showed any significant antiviral activities against HIV-1, HBV, HSV-1 and HSV-2 in vitro up to 100 microM.

UI MeSH Term Description Entries
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D018258 Herpesvirus 2, Human A species of SIMPLEXVIRUS associated with genital infections (HERPES GENITALIS). It is transmitted by sexual intercourse and close personal contact. HSV-2,Herpes Simplex Virus 2,Human Herpesvirus 2,HHV-2,Herpes Simplex Virus Type 2,Herpesvirus 2 (alpha), Human
D018259 Herpesvirus 1, Human The type species of SIMPLEXVIRUS causing most forms of non-genital herpes simplex in humans. Primary infection occurs mainly in infants and young children and then the virus becomes latent in the dorsal root ganglion. It then is periodically reactivated throughout life causing mostly benign conditions. HSV-1,Herpes Simplex Virus 1,HHV-1,Herpes Simplex Virus Type 1,Herpesvirus 1 (alpha), Human,Human Herpesvirus 1

Related Publications

C Pierra, and S Olgen, and S C Cavalcanti, and Y C Cheng, and R F Schinazi, and C K Chu
Enantiomeric Synthesis of L-(or 1'R,2'S)-Carbocyclic Cyclopropyl Nucleosides.
April 1997, The Journal of organic chemistry,
C Pierra, and S Olgen, and S C Cavalcanti, and Y C Cheng, and R F Schinazi, and C K Chu
Synthesis and antiviral activity of novel C-methyl branched cyclopropyl nucleosides.
September 2003, Archives of pharmacal research,
C Pierra, and S Olgen, and S C Cavalcanti, and Y C Cheng, and R F Schinazi, and C K Chu
Synthesis and antiviral evaluation of novel methyl branched cyclopropyl phosphonic acid nucleosides.
July 2005, Archives of pharmacal research,
C Pierra, and S Olgen, and S C Cavalcanti, and Y C Cheng, and R F Schinazi, and C K Chu
Synthesis and antiviral activities of 1,3-oxathiolanyl nucleosides with 5-hydroxymethyl substituent.
January 1999, Nucleosides & nucleotides,
C Pierra, and S Olgen, and S C Cavalcanti, and Y C Cheng, and R F Schinazi, and C K Chu
Synthesis and antiviral activity of novel methylene cyclopropyl nucleosides.
December 2000, Archives of pharmacal research,
C Pierra, and S Olgen, and S C Cavalcanti, and Y C Cheng, and R F Schinazi, and C K Chu
Synthesis and antiviral activity of novel exomethylene cyclopropyl nucleosides.
January 2001, Nucleosides, nucleotides & nucleic acids,
C Pierra, and S Olgen, and S C Cavalcanti, and Y C Cheng, and R F Schinazi, and C K Chu
Synthesis and antiviral evaluation of novel cyclopropyl nucleosides, phosphonate nucleosides and phosphonic acid nucleosides.
September 2006, Archiv der Pharmazie,
C Pierra, and S Olgen, and S C Cavalcanti, and Y C Cheng, and R F Schinazi, and C K Chu
Synthesis and antiviral activity of novel exomethylene cyclopropyl pyrimidine nucleosides.
December 2002, Archives of pharmacal research,
C Pierra, and S Olgen, and S C Cavalcanti, and Y C Cheng, and R F Schinazi, and C K Chu
Synthesis and antiviral activity of C-fluoro-branched cyclopropyl nucleosides.
April 2007, European journal of medicinal chemistry,
C Pierra, and S Olgen, and S C Cavalcanti, and Y C Cheng, and R F Schinazi, and C K Chu
Racemic synthesis and antiviral evaluation of 4'(alpha)-hydroxymethyl and 6'(alpha)-methyl substituted apiosyl nucleosides.
January 2007, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!